col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


119 Results       Page 1

 [1] 
Wiley: Transfusion
  original article Date Title Authors   All Authors
1 [GO] 2024―Feb―08 Charting a path forward: Promising outcomes of convalescent plasma therapy in the care of severely B-cell depleted patients with persistent COVID-19 Tsofia Inbar, Eldad J. Dann, Omer Kerner, Anat Stern
2 [GO] 2023―Dec―29 Safety of COVID-19 convalescent plasma: A definitive systematic review and meta-analysis of randomized controlled trials Massimo Franchini, Mario Cruciani, Arturo Casadevall, Michael J. Joyner, Jonathon W. Senefeld, David J. Sullivan, et al. (+2)
3 [GO] 2023―Dec―13 Risk of transfusion-transmitted infection with severe acute respiratory syndrome coronavirus 2 from blood donors in Japan Naoya Shinohara, Mai Ito, Kazuhiro Kai, Noriyuki Kamo, Takashi Owada, Rieko Sobata, et al. (+9)
4 [GO] 2023―Dec―06 Clinical outcomes in hospitalized plasma and platelet transfusion recipients prior to and following widespread blood donor SARS-CoV-2 infection and vaccination Nareg H. Roubinian, John Greene, Vincent X. Liu, Catherine Lee, Dustin G. Mark, David R. Vinson, et al. (+8)
5 [GO] 2023―Sep―13 In response: How increased rates of high blood-utilization events may have influenced blood usage during the COVID-19 pandemic Jeremy W. Jacobs, Garrett S. Booth, Brian D. Adkins
6 [GO] 2023―Aug―24 Characterization of antibodies to SARS-CoV-2 in lyophilized plasma prepared with amotosalen-UVA pathogen reduction Christophe Martinaud, Anil Bagri, Cheng-Ting Tsai, Rafael R. de Assis, Michelle Gatmaitan, Peter V. Robinson, et al. (+4)
7 [GO] 2023―Aug―03 Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials Moises A. Huaman, Jay S. Raval, James H. Paxton, Giselle S. Mosnaim, Bela Patel, Shweta Anjan, et al. (+52)
8 [GO] 2023―Jul―08 Apheresis medicine education during the early phase of the COVID-19 pandemic Angela Treml, Sarita A. Joshi, Laura Dilly Stephens, Nicole D. Zantek, Yvette C. Tanhehco, Holli M. Mason, et al. (+5)
9 [GO] 2023―May―31 SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022 Evan M. Bloch, Dorothy Kyeyune, Jodie L. White, Henry Ddungu, Swetha Ashokkumar, Feben Habtehyimer, et al. (+31)
10 [GO] 2023―May―10 Trend of blood donors entering the coronavirus pandemic era and challenges: Age-period-cohort analysis using 75.5 million all blood donations data during 2006-2020 in Japan Hirohito Imada, Tomoyuki Akita, Aya Sugiyama, Junko Tanaka
11 [GO] 2023―Apr―13 Impact of the COVID -19 pandemic on blood donation and transfusions in the United States in 2020 Sridhar V. Basavaraju, Rebecca J. Free, Joel L. Chavez Ortiz, Phylicia Stewart, James Berger, Mathew R. P. Sapiano
12 [GO] 2023―Mar―16 Assessing deviations for HPCs obtained during COVID -19 ( ADHOC ): Evaluating impact of the COVID -19 pandemic on cellular therapy products and processes, the BEST collaborative study Suzanne R. Thibodeaux, Dean Coble, Victoria Day, Magali J. Fontaine, Maria Gabelli, Nicola Gardiner, et al. (+5)
13 [GO] 2023―Feb―07 Perception of blood donation among employees of healthcare organizations during COVID -19 pandemic: A national multicenter cross-sectional study Lubna Al Zadjali, Khalid Batarfi, Maha Badawi, Ghada Elgohary, Mansour Aljabry, Omar Alsuhaibani, et al. (+3)
14 [GO] 2022―Dec―27 Inactivation of SARS-CoV -2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light Jody Hobson-Peters, Alberto A. Amarilla, Lina Rustanti, Denese C. Marks, Eileen Roulis, Alexander A. Khromykh, et al. (+8)
15 [GO] 2022―Dec―23 Demographics of first-time donors returning for donation during the pandemic: COVID -19 convalescent plasma versus standard blood product donors Nancy L. Van Buren, Srijana Rajbhandary, Vanessa Reynolds, Jed B. Gorlin, Susan L. Stramer, Edward P. Notari, et al. (+13)
16 [GO] 2022―Nov―08 Comparison of allocation strategies of convalescent plasma to reduce excess infections and mortality from SARS-CoV -2 in a US -like population Natalya Kostandova, Emmanuel Fulgence Drabo, Karine Yenokyan, Amy Wesolowski, Shaun Truelove, Evan M. Bloch, et al. (+6)
17 [GO] 2022―Oct―07 ‘Stay at home and limit contact’: The impact of stay-at-home advice on the behavior of Australian donors aged 70 and over in the first year of the pandemic Sanda Naing, Rachel Thorpe, Kyle Jensen, Barbara Masser, Nicky Guerin
18 [GO] 2022―Sep―12 Blood conservation strategies at United States hospitals during the COVID-19 pandemic: Findings from a multi-institutional analysis Jeremy W. Jacobs, Matthew S. Karafin, Elizabeth S. Allen, Elizabeth Abels, Yara A. Park, Laura D. Stephens, et al. (+5)
19 [GO] 2022―Aug―21 Neutralization profile of SARS-CoV -2 Omicron BA .1 variant in high binding titer plasma Lukas Kevlicius, Dovile Juozapaite, Lina Kryzauskaite, Migle Montrimaite, Karolis Sablauskas, Daniel Naumovas, Laimonas Griskevicius
20 [GO] 2022―Jul―09 Hospital red blood cell and platelet supply and utilization from March to December of the first year of the COVID-19 pandemic: The BEST Collaborative Study Wen Lu, Mark Yazer, Na Li, Alyssa Ziman, Silvano Wendel, Hongying Tang, et al. (+18)
21 [GO] 2022―Jun―28 Simulated red cell antibody identification training panels created using SARS-CoV -2 kodecytes and immune plasma Holly Perry, Stephen M. Henry
22 [GO] 2022―Jun―23 Implementation of a dual platelet inventory in a tertiary hospital during the COVID -19 pandemic enabling cold-stored apheresis platelets for treatment of actively bleeding patients Hanne Braathen, Kristin G. Hagen, Einar K. Kristoffersen, Geir Strandenes, Torunn O. Apelseth
23 [GO] 2022―May―30 Freeze-dried plasma: From damage control resuscitation to coronavirus disease 2019 therapy Henry T. Peng, Shawn G. Rhind, Katy Moes, Dana Devine, Craig Jenkins, Andrew Beckett
24 [GO] 2022―May―24 How do we …form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry? Rebecca V. Fink, Lois Fisher, Hasan Sulaeman, Honey Dave, Matthew E. Levy, Lily McCann, et al. (+17)
25 [GO] 2022―May―19 Convalescent plasma donors show enhanced cross-reactive neutralising antibody response to antigenic variants of SARS-CoV-2 following immunisation Heli Harvala, Dung Nguyen, Peter Simmonds, Abigail A. Lamikanra, Hoi Pat Tsang, Ashley Otter, et al. (+12)
26 [GO] 2022―May―19 Hyperhemolysis in a patient with sickle cell disease and recent SARS-COV-2 infection, with complex auto- and allo-antibody work-up, successfully treated with tocilizumab C. Fuja, V. Kothary, T. Carll, S. Singh, P. Mansfield, G. D. Wool
27 [GO] 2022―Apr―15 Neutralizing antibody levels against Sars-CoV-2 Variants of concern delta and omicron in vaccine Breakthrough-Infected blood donors Massimo Franchini, Daniele Focosi, Carlo Mengoli, Elena Percivalle, Josè Camilla Sammartino, Alessandro Ferrari, et al. (+3)
28 [GO] 2022―Mar―26 Efficacy of early transfusion of convalescent plasma with high-titer SARS-CoV -2 neutralizing antibodies in hospitalized patients with COVID -19 Cristina Sanz, Meritxell Nomdedeu, Arturo Pereira, Silvia Sauleda, Rodrigo Alonso, Marta Bes, et al. (+9)
29 [GO] 2022―Feb―22 Passive Transfer of SARS-CoV -2 Antibodies with Platelet Transfusions Guillermo Ramirez, Pranisha Gautam-Goyal, Sherry Shariatmadar, Akshay Khatri, Molly McCann-Pineo, Rehana Rasul, et al. (+5)
30 [GO] 2022―Feb―07 SARS-CoV -2 and the safety of blood donations: time for a brave revision? Daniele Focosi, Massimo Franchini
31 [GO] 2022―Feb―07 Vaccination of COVID -19 Convalescent Plasma Donors Increases Binding and Neutralizing Antibodies Against SARS-CoV -2 Variants Clara Di Germanio, Graham Simmons, Chloe Thorbrogger, Rachel Martinelli, Mars Stone, Thomas Gniadek, Michael P. Busch
32 [GO] 2022―Jan―31 Experience with COVID -19 convalescent plasma provides vital guidance to future pandemics Jan Hartmann, Evan M. Bloch, Thierry Burnouf
33 [GO] 2022―Jan―13 COVID-19 and the impact on blood availability and transfusion practices in low- and middle-income countries Linda S. Barnes, Arwa Z. Al-Riyami, Tina S. Ipe, Evan M. Bloch, Cees Smit Sibinga, Quentin G. Eichbaum
34 [GO] 2021―Dec―22 Absence of correlation between ABO Rh(D) blood group and neutralizing antibody titers in SARS-CoV -2 convalescent plasma donors Rena Hirani, Veronica Hoad, Iain B. Gosbell, David O. Irving
35 [GO] 2021―Dec―06 Impact of different pathogen reduction technologies on the biochemistry, function, and clinical effectiveness of platelet concentrates: An updated view during a pandemic Gines Escolar, Maribel Diaz-Ricart, Jeffrey McCullough
36 [GO] 2021―Nov―15 Regulatory challenges of convalescent plasma collection during the evolving stages of COVID-19 pandemic in the US Sajjad Hassan, Kamille A. West, Kathleen Conry-Cantilena, Valeria De Giorgi
37 [GO] 2021―Oct―21 Surrogate test performance for SARS-CoV -2 neutralizing antibodies ( nAbs ) for convalescent plasma ( CCP ): how useful could they be? Silvano Wendel, Roberta Fachini, Rita C. L. Fontão-Wendel, Ralyria Mello, Carlos Vinícius Velasquez, Rafael Rahal Guaragna Machado, et al. (+8)
38 [GO] 2021―Oct―20 Resistance of SARS-CoV -2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020 Steven J. Drews, Kento T. Abe, Queenie Hu, Reuben Samson, Anne-Claude Gingras, Karen Colwill, et al. (+11)
39 [GO] 2021―Oct―19 Trends and risk factors of SARS-CoV -2 infection in asymptomatic blood donors Luca Valenti, Serena Pelusi, Alessandro Cherubini, Cristiana Bianco, Luisa Ronzoni, Sara Uceda Renteria, et al. (+10)
40 [GO] 2021―Sep―22 Severe Autoimmune Hemolytic Anemia Following Receipt of SARS-CoV -2 mRNA Vaccine Sanjay R. V. Gadi, Patricia A. R. Brunker, Hanny Al-Samkari, David B. Sykes, Rebecca R. Saff, Janet Lo, et al. (+3)
41 [GO] 2021―Sep―21 Detection of SARS-CoV -2-independent immunoregulatory activity of COVID -19 convalescent plasma Regine Brox, Susanne Achenbach, Holger Hackstein
42 [GO] 2021―Sep―09 A novel competition ELISA for the rapid quantification of SARS-CoV -2 neutralizing antibodies in convalescent plasma Elise Wouters, Caro Verbrugghe, Rosalie Devloo, Isabelle Debruyne, Dorien De Clippel, Leen Van Heddegem, et al. (+6)
43 [GO] 2021―Sep―07 Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID -19 pandemic Oksana Prokopchuk-Gauk, Tanya Petraszko, Susan Nahirniak, Cheryl Doncaster, Isra Levy
44 [GO] 2021―Sep―01 Hospital transfusion service operations during the SARS-CoV -2 pandemic: Lessons learned from the AABB hospital survey in preparation for the next infectious disease outbreak Srijana Rajbhandary, Aaron Shmookler, Claudia S. Cohn, Eduardo Nunes, Matthew S. Karafin, James Stubbs, Monica B. Pagano
45 [GO] 2021―Aug―08 Assessment of the potentially decreased neutralizing activities of intravenous immunoglobulin against future coronavirus variants Takamasa Inoue, Mikihiro Yunoki, Ritsuko Kubota-Koketsu, Tatsuo Shioda
46 [GO] 2021―Aug―03 Comparability of six different immunoassays measuring SARS-CoV -2 antibodies with neutralising antibody levels in convalescent plasma: from utility to prediction Abigail Lamikanra, Dung Nguyen, Peter Simmonds, Sarah Williams, Emma M. Bentley, Cathy Rowe, et al. (+16)
47 [GO] 2021―Jul―16 Treating the endotheliopathy of SARS-CoV -2 infection with plasma: Lessons learned from optimized trauma resuscitation with blood products Shibani Pati, Erin Fennern, John B. Holcomb, Mark Barry, Alpa Trivedi, Andrew P. Cap, et al. (+7)
48 [GO] 2021―Jun―21 Lewis and ABO histo-blood types and the secretor status of patients hospitalized with COVID -19 implicate a role for ABO antibodies in susceptibility to infection with SARS-CoV -2 Eva Maria Matzhold, Andrea Berghold, Maria Karin Berta Bemelmans, Chiara Banfi, Evelyn Stelzl, Harald Hans Kessler, et al. (+5)
49 [GO] 2021―Jun―14 SARS-CoV -2 Antibody persistence in COVID -19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance Clara Di Germanio, Graham Simmons, Kathleen Kelly, Rachel Martinelli, Orsolya Darst, Mahzad Azimpouran, et al. (+12)
50 [GO] 2021―May―28 Minipool testing for SARS-CoV -2 RNA in United States blood donors Sonia Bakkour, Paula Saá, Jamel A. Groves, Leilani Montalvo, Clara Di Germanio, Sonja M. Best, et al. (+12)
51 [GO] 2021―May―27 Are We Forgetting About IgA? A Re-examination of Coronavirus Disease 2019 Convalescent Plasma Hans Verkerke, Bejan J. Saeedi, Darra Boyer, Jerry W. Allen, Joshua Owens, Sooncheon Shin, et al. (+15)
52 [GO] 2021―May―26 The effect of the SARS-CoV -2 pandemic and civil unrest on massive transfusion protocol activations in Minneapolis 2020 Alexander L. Braun, Jed B. Gorlin, Jessica Peters, Sherrie Murphy, Nancy L. Van Buren
53 [GO] 2021―May―26 Blood group O convalescent plasma donations have significantly lower levels of SARS-CoV -2 IgG antibodies compared to blood group A donations Chelsea Hayes, Wesley Rubenstein, David Gibb, Ellen Klapper, Julie Tanaka, Samuel Pepkowitz
54 [GO] 2021―May―15 Impact of the early COVID -19 pandemic on blood utilization in the United States: a time-series analysis of data reported to the National Healthcare Safety Network Hemovigilance Module Ian Kracalik, Sanjida Mowla, Louis Katz, Melissa Cumming, Matthew R. P. Sapiano, Sridhar V. Basavaraju
55 [GO] 2021―May―09 We stand ready … Blood collection organizations and the COVID -19 pandemic Hany Kamel
56 [GO] 2021―Apr―27 Implementation of Measures to Improve Blood Collection Center Employee Safety and Reduce Callouts During The COVID -19 Pandemic Emily Coberly, Erin Korich, Michelle Henesy, Kate Doerksen, Pampee Young
57 [GO] 2021―Apr―21 Blood usage at a large academic center in Maryland in relation to the COVID -19 pandemic in 2020 Colin Murphy, Magali Fontaine, Paul Luethy, Heather McGann, Bryon Jackson
58 [GO] 2021―Mar―08 The Impact of ABO Blood Group on Clinical Outcomes and Susceptibility to COVID-19: A Retrospective Study in an Unselected Population Sarah A. Al-Youha, Waleed Alduaij, Ahmad Al-Serri, Sulaiman M. Almazeedi, Mohannad Al-Haddad, Mohammad H. Jamal, et al. (+2)
59 [GO] 2021―Mar―08 Planned haematopoietic stem cell transplantation in a 17-month-old patient with high-risk acute myeloid leukaemia and persistent SARS-CoV -2 infection Daniela Cuzzubbo, Francesco Pegoraro, Stefano Frenos, Tommaso Casini, Luisa Galli, Eleonora Gambineri, et al. (+3)
60 [GO] 2021―Mar―05 ABO blood type association with SARS-CoV -2 infection mortality: A single-center population in New York City James Szymanski, Laurel Mohrmann, Jamal Carter, Randin Nelson, Sweta Chekuri, Andrei Assa, et al. (+5)
61 [GO] 2021―Mar―01 National level adjustments to the challenges of the SARS-CoV2 pandemic on blood banking operations Andrea Matusovits, Sándor Nagy, Klára Baróti-Tóth, János Nacsa, Mária Lázár, Imelda Marton, et al. (+3)
62 [GO] 2021―Feb―26 New blood donors in times of crisis: Increased donation willingness, particularly among people at high risk for attracting SARS-CoV -2 Marloes L. C. Spekman, Steven Ramondt, Franke A. Quee, Femmeke J. Prinsze, Elisabeth M. J. Huis in 't Veld, Katja Hurk, Eva-Maria Merz
63 [GO] 2021―Feb―23 Apheresis Physician Well-Being During the COVID -19 Pandemic: Results of a Survey Yvette C. Tanhehco, Yanhua Li, Nicole D. Zantek, Joanne Becker, Mohamed Alsammak, Kael Mikesell, et al. (+5)
64 [GO] 2021―Feb―22 Longitudinal analysis of SARS-CoV -2 antibodies in 8000 U.S. first-time convalescent plasma donations Michael Karbiener, Maria R. Farcet, Reinhard Ilk, Jessica Schreiner, James Lenart, Nicholas Powers, et al. (+3)
65 [GO] 2021―Feb―20 A longitudinal study of convalescent plasma ( CCP ) donors and correlation of ABO group, initial neutralizing antibodies ( nAb ), and body mass index ( BMI ) with nAb and anti-nucleocapsid ( NP ) SARS-CoV -2 antibody kinetics: Proposals for better quality of CCP collections Silvano Wendel, Rita Fontão-Wendel, Roberta Fachini, Gabriela Candelaria, Patricia Scuracchio, Ruth Achkar, et al. (+8)
66 [GO] 2021―Feb―20 High-throughput detection of antibodies targeting the SARS-CoV -2 Spike in longitudinal convalescent plasma samples Sai Priya Anand, Jérémie Prévost, Jonathan Richard, Josée Perreault, Tony Tremblay, Mathieu Drouin, et al. (+4)
67 [GO] 2021―Feb―17 COVID -19 antibody screening with SARS-CoV -2 red cell kodecytes using routine serologic diagnostic platforms Radhika Nagappan, Willy A. Flegel, Kshitij Srivastava, Eleanor C. Williams, Ivan Ryzhov, Alexander Tuzikov, et al. (+6)
68 [GO] 2021―Feb―14 Decrease in serum antibodies to SARS-CoV -2 in convalescent plasma donors over time Kristina Prus, Caroline R. Alquist, Jose A. Cancelas, David Oh
69 [GO] 2021―Feb―14 Testing for the presence of SARS-CoV -2 RNA in presymptomatic blood donors Lionel Loubaki, Pierre Gantner, Amélie Pagliuzza, Hugues Fausther-Bovendo, Gary Kobinger, Nicolas Chomont, Marc Germain
70 [GO] 2021―Feb―08 Pandemic Blood Donor Demographics - Do Changes Impact Blood Safety? Ralph R. Vassallo, Marjorie D. Bravo, Hany Kamel
71 [GO] 2021―Feb―08 Selecting COVID -19 Convalescent Plasma for Neutralizing Antibody Potency Using a High-capacity SARS-CoV -2 Antibody Assay E. Goodhue Meyer, G. Simmons, E. Grebe, M. Gannett, S. Franz, O. Darst, et al. (+10)
72 [GO] 2021―Feb―03 SARS-CoV -2 seroprevalence among blood donors after the first COVID -19 wave in Canada Sahar Saeed, Steven J. Drews, Chantale Pambrun, Qi-Long Yi, Lori Osmond, Sheila F. O’Brien
73 [GO] 2021―Jan―25 Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing Alfredo Mendrone-Junior, Carla Luana Dinardo, Suzete Cleuza Ferreira, Anna Nishya, Nanci Alves Salles, Cesar Almeida Neto, et al. (+8)
74 [GO] 2021―Jan―18 Covid-19 Convalescent Plasma Donor Characteristics, Product Disposition and Comparison With Standard Apheresis Donors Baia Lasky, Erin Goodhue Meyer, Whitney R Steele, Lauren A. Crowder, Pampee P. Young
75 [GO] 2021―Jan―16 Presence and short-term persistence of SARS-CoV -2 neutralizing antibodies in COVID -19 convalescent plasma donors Kyle Annen, Thomas E. Morrison, Melkon G. DomBourian, Mary K. McCarthy, Leah Huey, Patricia A. Merkel, et al. (+3)
76 [GO] 2021―Jan―16 Adaptations of transfusion systems to the COVID -19 pandemic in British Columbia, Canada : Early experiences of a large tertiary care center and survey of provincial activities Eric McGinnis, Robert J. Guo, Krista M. Marcon, Brian Berry, Robert Coupland, Victor Meneghetti, et al. (+6)
77 [GO] 2021―Jan―15 Neutralizing Activity to SARS-CoV-2 of Convalescent and Control Plasma Used in a Randomized Controlled Trial Alex T. Freedenberg, Chun-Hao Pan, William E. Diehl, Jamie L. Romeiser, Ga-Ram Hwang, Cindy V. Leiton, et al. (+3)
78 [GO] 2020―Dec―25 De novo acquired hemophilia as an immune dysregulation phenomenon following SARS-CoV -2 infection Gregory M. Olsen, Henry M. Rinder, Christopher A. Tormey
79 [GO] 2020―Dec―25 Simple Modifications of Therapeutic Plasma Exchange Treatments during the SARS-CoV -2 Pandemic Jack Khouri, Jennifer Royer, Heather Howdyshell, Shannon Homolish, Linda Salmi, Viva Veemara, et al. (+2)
80 [GO] 2020―Dec―04 COVID-19 associated with severe autoimmune hemolytic anemia Jeremy Jacobs, Quentin Eichbaum
81 [GO] 2020―Nov―24 Therapeutic Plasma Exchange for COVID-19-Associated Hyperviscosity Alexander D. Truong, Sara C. Auld, Nicholas A. Barker, Sarah Friend, A. Thanushi Wynn, Jason Cobb, et al. (+14)
82 [GO] 2020―Nov―21 Transfusion services operations during the COVID -19 pandemic: Results from AABB survey Monica B. Pagano, Srijana Rajbhandary, Eduardo Nunes, Claudia S. Cohn
83 [GO] 2020―Nov―20 Blood component utilization in COVID-19 patients in New York City : Transfusions do not follow the curve Robert A. DeSimone, Victoria A. Costa, Kathleen Kane, Jorge L. Sepulveda, Grant B. Ellsworth, Roy M. Gulick, et al. (+4)
84 [GO] 2020―Nov―16 Lack of association between SNPsrs8176719(O blood group) and COVID-19: data from Spanish age matched patients and controls Eliecer Coto, Guillermo M. Albaiceta, Marta G. Clemente, Juan Gómez
85 [GO] 2020―Nov―04 Transfusion support in COVID-19 patients: Impact on hospital blood component supply during the outbreak Kyra Velázquez-Kennedy, Alejandro Luna, Adrián Sánchez-Tornero, Carlos Jiménez-Chillón, Ana Jiménez-Martín, Ana Vallés Carboneras, et al. (+4)
86 [GO] 2020―Oct―30 Transfusion Reactions Associated with COVID -19 Convalescent Plasma Therapy for SARS-CoV -2 Freddy T. Nguyen, Tayler Akker, Kimberly Lally, Hansen Lam, Volha Lenskaya, Sean T. H. Liu, et al. (+40)
87 [GO] 2020―Oct―30 Validation of a SARS-CoV -2 RNA RT-PCR assay for high-throughput testing in blood of COVID -19 convalescent plasma donors and patients EF Strasser, PA Steininger, K Korn, S Achenbach, M Tenbusch, S Cunningham, et al. (+3)
88 [GO] 2020―Oct―26 Neutralizing and binding activities against SARS-CoV -1/2, MERS-CoV , and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan Ritsuko Kubota-Koketsu, Yutaka Terada, Mikihiro Yunoki, Tadahiro Sasaki, Emi E. Nakayama, Wataru Kamitani, Tatsuo Shioda
89 [GO] 2020―Oct―10 Seroreactivity with COVID 19 antibody testing in CCP donors presenting without a SARS-CoV-2 diagnostic test Erin K. Goodhue Meyer, Meng Xu, Baia Lasky, Pampee Young
90 [GO] 2020―Oct―08 Transition from Room-Temperature to Cold-Stored Platelets for the Preservation of Blood Inventories during the COVID-19 Pandemic Matthew A Warner, Emil B. Kurian, Scott A. Hammel, Camille M. van Buskirk, Daryl J. Kor, James R. Stubbs
91 [GO] 2020―Oct―03 Evaluating Blood Product Quality Post Expiry to Mitigate Blood Shortages During the COVID -19 Pandemic in Canada Tracey R. Turner, Carly Olafson, Olga Mykhailova, April Xu, Jason P. Acker
92 [GO] 2020―Sep―29 Provision of COVID-19 Convalescent Plasma in a Resource-Constrained State Tina S. Ipe, Tuan Le, Brian Quinn, Stan Kellar, Melisa Clark, Suzanna Carlisle, et al. (+9)
93 [GO] 2020―Sep―26 Characterization of 100 sequential SARS-CoV-2 convalescent plasma donations Christof Jungbauer, Lukas Weseslindtner, Lisa Weidner, Simon Gänsdorfer, Maria R. Farcet, Eva Gschaider-Reichhart, Thomas R. Kreil
94 [GO] 2020―Sep―26 The Need for an Artificial Oxygen Carrier for Disasters and Pandemics, Including COVID -19 Richard B. Weiskopf, Elon Glassberg, Nicole Guinn, Michael F.M. James, Paul M. Ness, Anthony E. Pusateri
95 [GO] 2020―Sep―21 Exploring predictors of Australian community members' blood donation intentions and blood donation-related behavior during the COVID-19 pandemic Barbara M Masser, Melissa K Hyde, Eamonn Ferguson
96 [GO] 2020―Sep―16 Screening for SARS-CoV -2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program Silvano Wendel, Jose Mauro Kutner, Rafael Machado, Rita Fontão-Wendel, Carolina Bub, Roberta Fachini, et al. (+15)
97 [GO] 2020―Sep―16 SARS-CoV -2 neutralization and serology testing of COVID -19 convalescent plasma from donors with non-severe disease Thomas J. Gniadek, Joshua M. Thiede, William E. Matchett, Abigail R. Gress, Kathryn A. Pape, Jessica K. Fiege, et al. (+4)
98 [GO] 2020―Aug―28 Blood use and transfusion needs at a large health care system in Washington state during the SARS-CoV -2 pandemic Monica B. Pagano, Guido Cataife, Kleber Yotsumoto Fertrin, Terry Gernsheimer, John R. Hess, Elizabeth Staley, et al. (+4)
99 [GO] 2020―Aug―28 Supply and demand for plasma-derived medicinal products - a critical re-assessment amidst the COVID -19 pandemic Jan Hartmann, Harvey G. Klein
100 [GO] 2020―Aug―25 Persistence of SARS-CoV -2 nasopharyngeal swab PCR positivity in COVID -19 convalescent plasma donors Sachie Ikegami, Robert Benirschke, Tara Flanagan, Nicole Tanna, Tovah Klein, Rita Elue, et al. (+6)
101 [GO] 2020―Aug―20 TRANSFUSION MEDICINE DURING COVID-19 OUTBREAK IN THE HOTSPOT OF SPAIN D Hernández-Maraver, A Viejo, AE Kerguelén, V Jiménez-Yuste
102 [GO] 2020―Aug―15 Risk of Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 by Transfusion: A Literature Review Jean-François Leblanc, Marc Germain, Gilles Delage, Sheila O’Brien, Steven J. Drews, Antoine Lewin
103 [GO] 2020―Aug―15 Development and Evaluation of a Novel RT-PCR System for Reliable and Rapid SARS-CoV-2 Screening of Blood Donations Meng Li, Yuwei Zhao, Ying Li, Xue Chen, Dongxia Luo, Mei Luo, et al. (+13)
104 [GO] 2020―Aug―10 Tools for rapid analysis of blood usage and inventory during the COVID -19 pandemic Colin Murphy, Bryon Jackson, Magali Fontaine
105 [GO] 2020―Aug―08 Lessons learned from early compassionate use of convalescent plasma on critically ill patients with Covid-19 Miao Liu, Zhen Chen, Meng-Yuan Dai, Jun-Hui Yang, Xiao-Bing Chen, Di Chen, et al. (+11)
106 [GO] 2020―Jul―16 Blood stewardship: Conservation and supply of blood components during the SARS-CoV -2 pandemic Sarah Vossoughi, Katherine Fischkoff, Robert A. DeSimone, Joseph Schwartz
107 [GO] 2020―Jul―15 No evidence of SARS-CoV -2 RNA among blood donors: A multicenter study in Hubei, China Le Chang, Ying Yan, Lei Zhao, Guibin Hu, Lijuan Deng, Dan Su, et al. (+10)
108 [GO] 2020―Jul―06 Blood Donor Recruitment in Guangzhou, China, during the 2019 Novel Coronavirus ( COVID -19) Epidemic Jian Ou-Yang, Shi-Jie Li, Chun-hua Bei, Bo He, Jin-yan Chen, Hua-qin Liang, Yong-shui Fu
109 [GO] 2020―Jul―06 Novel multiple swab method enables high efficiency in SARS-CoV -2 screenings without loss of sensitivity for screening of a complete population Michael Schmidt, Sebastian Hoehl, Annemarie Berger, Heinz Zeichhardt, Kai Hourfar, Sandra Ciesek, Erhard Seifried
110 [GO] 2020―Jun―25 How the COVID -19 Pandemic Changed Cellular Therapy at Columbia University Irving Medical Center/ NewYork-Presbyterian Hospital Yvette C. Tanhehco, Joseph Schwartz
111 [GO] 2020―Jun―20 COVID-19 and ABO blood groups Sunny Dzik, Kent Eliason, Edward B. Morris, Richard M Kaufman, Crystal M. North
112 [GO] 2020―Jun―16 Effective coronavirus reduction by various production steps during the manufacture of plasma-derived medicinal products Tobias Schräder, Julia Koch, Rachael Ross, Wolfram Schäfer, Björn Keiner, Nathan J. Roth, Eleonora Widmer
113 [GO] 2020―Jun―16 Is SARS-CoV -2 transfusion transmitted? Louis M. Katz
114 [GO] 2020―Jun―03 Feasibility of a Pilot Program for COVID-19 Convalescent Plasma Collection in Wuhan, China Ling Li, Ru Yang, Jue Wang, Qilu Lv, Ming Ren, Lei Zhao, et al. (+12)
115 [GO] 2020―May―06 Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design Paul Barone, Robert A. DeSimone
116 [GO] 2020―May―06 COVID-19 convalescent plasma: phase 2 C. Michael Knudson, J. Brooks Jackson
117 [GO] 2020―May―03 SARS-CoV -2 asymptomatic and symptomatic patients and risk for transfusion transmission Victor M. Corman, Holger F. Rabenau, Ortwin Adams, Doris Oberle, Markus B. Funk, Brigitte Keller-Stanislawski, et al. (+3)
118 [GO] 2020―May―02 Convalescent plasma: possible therapy for novel coronavirus disease 2019 Huiling Cao, Yuan Shi
119 [GO] 2020―Mar―21 Prepare to adapt: Blood supply and transfusion support during the first 2 weeks of the 2019 Novel Coronavirus (COVID-19) pandemic affecting Washington State Monica B. Pagano, John R. Hess, Hamilton C. Tsang, Elizabeth Staley, Terry Gernsheimer, Nina Sen, et al. (+4)
 [1] 

119 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.018 sec